Muutke küpsiste eelistusi

RNA Interference and Cancer Therapy: Methods and Protocols 2019 ed. [Pehme köide]

  • Formaat: Paperback / softback, 416 pages, kõrgus x laius: 254x178 mm, kaal: 817 g, 84 Illustrations, color; 28 Illustrations, black and white; XIII, 416 p. 112 illus., 84 illus. in color., 1 Paperback / softback
  • Sari: Methods in Molecular Biology 1974
  • Ilmumisaeg: 14-Aug-2020
  • Kirjastus: Humana Press Inc.
  • ISBN-10: 1493992228
  • ISBN-13: 9781493992225
Teised raamatud teemal:
  • Pehme köide
  • Hind: 104,29 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 122,69 €
  • Säästad 15%
  • Raamatu kohalejõudmiseks kirjastusest kulub orienteeruvalt 2-4 nädalat
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
  • Formaat: Paperback / softback, 416 pages, kõrgus x laius: 254x178 mm, kaal: 817 g, 84 Illustrations, color; 28 Illustrations, black and white; XIII, 416 p. 112 illus., 84 illus. in color., 1 Paperback / softback
  • Sari: Methods in Molecular Biology 1974
  • Ilmumisaeg: 14-Aug-2020
  • Kirjastus: Humana Press Inc.
  • ISBN-10: 1493992228
  • ISBN-13: 9781493992225
Teised raamatud teemal:
This comprehensive volume collects a repertoire of techniques for the adoption and exploitation of RNA interference (RNAi) as a fertile strategy to develop the bio-drugs of future in the vital field of cancer research. Exploring the immense ‘bench to bedside’ potential of RNAi as a therapeutic molecule, the book focuses many of its chapters on nanoparticle-based targeted deliveries, including aptamers, as well as techniques for using RNAi technology to combat various cancers in preclinical studies. Each of the 26 chapters is authored by the pioneers in the respective areas and thus provides a practical and empirical account of the techniques that could be used as benchmark tools in the area of cancer research. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. 

Authoritative and essential, RNA Interference and Cancer Therapy: Methods and Protocols provides the necessary guidance for both novice and professional researchers who intend to discover and innovate newer means of using RNAi technology to combat cancer, one of the greatest scourges of human health.
siRNA Library Screening to Identify Complementary Therapeutic Pairs in
Triple Negative Breast Cancer Cells.- In Vitro Evaluation of Candidate Gene
Targets for Cancer Therapy.- siRNA-Based Drug Targeting Human Bcl-xL against
Cancers.- Relative Quantification of siRNA Strand Loading into Ago2 for
Design of Highly-Active siRNAs.- VEGFA Gene Silencing in CXCR4-Expressing
Cells via siRNA Delivery by Means of Targeted Peptide Carrier.- Design
Strategy to Access siRNA-Encapsulating DNA Nanosuitcases that Can
Conditionally Release their Cargo.- Combinatorial siRNA Polyplexes for
Receptor Targeting.- Synthesis of Doxorubicin and miRNA Stimuli-Sensitive
Conjugates for Combination Therapy.- Minicell-Based Targeted Delivery of
shRNA to Cancer Cells: An Experimental Protocol.- Targeted Delivery of miRNA
Antagonists to Myeloid Cells In Vitro and In Vivo.- Systemic Modulation of
Lymphocyte Subsets Using siRNAs Delivered via Targeted Lipid Nanoparticles.-
Targeting Cancer with Peptide RNAi Nanoplexes.- Preparation of a Carrier to
Achieve In Vivo Delivery of siRNA: The Example of Chitosan-Coated
Poly(isobutylcyanoacrylate) Nanoparticles.- Monoclonal Antibody-Conjugated
Dendritic Nanostructures for siRNA Delivery.- Synthesis of Gold Nanoparticles
for Gene Silencing.- Design of Eco-Friendly Gold Nanoparticles for Cancer
Treatment.- 64Cu-Labeled Aptamers for Tumor-Targeted Radionuclide Delivery.-
Silencing PRDM14 via Oligonucleotide Therapeutics Suppresses Tumorigenicity
and Metastasis of Breast Cancer.- Bio-Drug Suppresses Breast and Colorectal
Cancer in Murine Models.- Combinatorial Nanoparticle Delivery of siRNA and
Antineoplastics for Lung Cancer Treatment.- Bioconjugated Gold Nanoparticles
Enhance siRNA Delivery in Prostate Cancer Cells.- Vaginal Suppositories with
siRNA and Paclitaxel-Incorporated Solid Lipid Nanoparticles for Cervical
Cancer: Preparation and In Vitro Evaluation.- The Use of Star Polymer
Nanoparticles for the Delivery of siRNA to Mouse Orthotopic Pancreatic Tumor
Models.- Microfluidic Assembly of siRNA-Loaded Micelleplexes for Tumor
Targeting in an Orthotopic Model of Ovarian Cancer.- Synthesis,
Physico-Chemical, and Biological Evaluation of Spherical Nucleic Acids for
RNAi-Based Therapy in Glioblastoma.- Folate-Decorated Polyamidoamine
Dendrimer Nanoparticles for Head and Neck Cancer Gene Therapy.